A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors
Clinical trial NCT06300216 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06300216
- Sponsor
- Qilu Hospital of Shandong University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-26
- Primary completion
- 2027-11-26
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.